Magnesium & Sleep

Magnesium & Sleep

Trouble falling asleep?  Magnesium plays four central roles in your sleep, and magnesium deficiency is heavily linked with major sleep disorders. On this page:

  1. Magnesium relaxes the body before sleep.
  2. Magnesium reduces and prevents sleep disorders.
  3. Magnesium regenerates your body and improves memory during sleep.
  4. Magnesium helps maintain a healthy biological clock (sleep cycle).
  5. Solutions to improving your sleep.
Learn More

1. Magnesium relaxes the body before sleep:

2. Magnesium reduces and prevents sleep disorders:

3. Magnesium promotes youth, recovery & memory during sleep:

4. Magnesium maintains a healthy biological clock (sleep cycle):

5. Solutions to help improve your sleep:

++ Scientific References

  1. Magnesium: Nature’s physiologic calcium blocker.
  2. Magnesium dependence of sarcoplasmic reticulum calcium transport.
  3. Effect of Magnesium on the Calcium-dependent Transient Kinetics of Sarcoplasmic Reticulum ATPase, Studied by Stopped Flow Fluorescence and Phosphorylation.
  4. Calcium efflux from cardiac sarcoplasmic reticulum: Effects of calcium and magnesium.
  5. The Binding of Calcium and Magnesium to Sarcoplasmic Reticulum Vesicles as Studied by Manganese Electron Paramagnetic Resonance.
  6. The role of glutamate in central nervous system health and disease–a review.
  7. Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology.
  8. GABA and glutamate in the human brain.
  9. Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations.
  10. The mechanism of magnesium block of NMDA receptors
  11. NMDA Receptor Function and Physiological Modulation
  12. Magnesium Sulfate Protects Against the Bioenergetic Consequences of Chronic Glutamate Receptor Stimulation.
  13. Magnesium potentiation of the function of native and recombinant GABA(A) receptors.
  14. Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium.
  15. Magnesium in the Central Nervous System
  16. Magnesium in neuroses and neuroticism. Regional Centre of Public Health, Iasi, Romania
  17. Magnesium sulphate has GABA-Agonistic effects on sleep in healthy men.
  18. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.
  19. Epidemiology of restless legs syndrome: a synthesis of the literature.
  20. Restless legs syndrome–theoretical roles of inflammatory and immune mechanisms.
  21. Increased prevalence of restless legs syndrome in patients with Crohn’s disease.
  22. Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome.
  23. Low-dose hydrocortisone in the evening modulates symptom severity in restless legs syndrome.
  24. The effect of vitamin D supplements on the severity of restless legs syndrome.
  25. An evaluation of sleep quality and the prevalence of restless leg syndrome in vitamin D deficiency.
  26. Possible association between vitamin D deficiency and restless legs syndrome.
  27. Serum 25-hydroxyvitamin D levels in restless legs syndrome patients.
  28. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1.
  29. Inflammation and vitamin D: the infection connection.
  30. The Impact of Vitamin D Levels on Inflammatory Status: A Systematic Review of Immune Cell Studies.
  31. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review).
  32. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway.
  33. Cytochromes P450 are essential players in the vitamin D signaling system.
  34. Cytochrome P450-mediated metabolism of vitamin D.
  35. Consider Magnesium Homeostasis: III: Cytochrome P450 Enzymes and Drug Toxicity.
  36. Magnesium Decreases Inflammatory Cytokine Production: A Novel Innate Immunomodulatory Mechanism.
  37. Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates.
  38. Magnesium Intake in Relation to Systemic Inflammation, Insulin Resistance, and the Incidence of Diabetes.
  39. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review:
  40. Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women.
  41. Ferritin subunits in CSF are decreased in restless legs syndrome.
  42. Is ferroportin-hepcidin signaling altered in restless legs syndrome?
  43. The role of iron in restless legs syndrome.
  44. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.
  45. Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging.
  46. The Role of Ceruloplasmin in Iron Metabolism.
  47. Multi-Copper Oxidases and Human Iron Metabolism.
  48. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.
  49. Reconstitution of ceruloplasmin by the Cu(I)-glutathione complex. Evidence for a role of Mg2+ and ATP.
  50. Iron, Free Radicals, and Oxidative Injury.
  51. Ferrotoxic Disease: The Next Great Public Health Challenge.
  52. Role of ceruloplasmin in inflammation: increased serum ceruloplasmin levels during inflammatory conditions and its possible relationship with anti-inflammatory agents.
  53. Glutathione Metabolism and Its Implications for Health.
  54. Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions.
  55. Glutathione and its role in cellular functions.
  56. Metabolism and functions of glutathione in brain.
  57. Oxidative stress in patients with obstructive sleep apnea syndrome.
  58. Oxidative stress and obstructive sleep apnea syndrome.
  59. Serum levels of magnesium and their relationship with CRP in patients with OSA.
  60. What is the Impact of Sleep Apnea on Canadians?
  61. Sleep Apnea Facts and Figures.
  62. Canadian Thoracic Society 2011 guideline update: Diagnosis and treatment of sleep disordered breathing.
  63. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.
  64. Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension.
  65. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.
  66. Obstructive sleep apnea and type 2 diabetes: interacting epidemics.
  67. Obstructive Sleep Apnea as a Risk Factor for Stroke and Death.
  68. Glutathione Biosynthesis.
  69. Glutathione Synthesis in Human Erythrocytes.
  70. Effects of Glutathione on Red Blood Cell Intracellular Magnesium.
  71. Biochemistry. 5th edition. Section 26.4Important Derivatives of Cholesterol Include Bile Salts and Steroid Hormones.
  72. Hormonal regulation of cytochrome P450 enzymes, cholesterol side-chain cleavage and 17 alpha-hydroxylase/C17-20 lyase in Leydig cells.
  73. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range.
  74. Memory consolidation during sleep: interactive effects of sleep stages and HPA regulation.
  75. Dehydroepiandrosterone (DHEA)–a precursor steroid or an active hormone in human physiology.
  76. Impaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol release.
  77. The Role of Slow Wave Sleep in Memory Processing.
  78. Slow-wave sleep and the consolidation of long-term memory.
  79. Midlife decline in declarative memory consolidation is correlated with a decline in slow wave sleep.
  80. The whats and whens of sleep-dependent memory consolidation.
  81. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.
  82. Sleep Selectively Enhances Memory Expected to Be of Future Relevance.
  83. Slow-Wave Sleep: Beyond Insomnia : The Importance of Slow-Wave Sleep for Your Patients.
  84. Human slow wave sleep: a review and appraisal of recent findings, with implications for sleep functions, and psychiatric illness.
  85. Restoration of brain energy metabolism as the function of sleep.
  86. Effects of different sleep duration on delta sleep in recovery nights.
  87. Enhancement of Slow Wave Sleep: Implications for Insomnia.
  88. Slow-wave sleep deficiency and enhancement: implications for insomnia and its management.
  89. The human “magnesome”: detecting magnesium binding sites on human proteins.
  90. Circadian rhythms and metabolic syndrome: from experimental genetics to human disease.
  91. The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks.
  92. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: A study of three different 24-h cycles over six weeks.
  93. Overview of circadian rhythms.
  94. Missing the Dark: Health Effects of Light Pollution.
  95. Circadian Rhythm Sleep Disorders.
  96. Circadian Rhythm Abnormalities.
  97. The Magnesium Factor – melatonin biosynthesis – oxidative stress, pg 172.
  98. Dietary factors and fluctuating levels of melatonin.
  99. Dietary magnesium deficiency decreases plasma melatonin in rats.
  100. Physiological and metabolic functions of melatonin.
  101. Melatonin as a chronobiotic.
  102. Melatonin, hormone of darkness and more – occurrence, control mechanisms, actions and bioactive metabolites.
  103. Melatonin receptors: role on sleep and circadian rhythm regulation.
  104. Physiology and pharmacology of melatonin in relation to biological rhythms.
  105. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
  106. Melatonin and its relation to the immune system and inflammation.
  107. Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats.
  108. Melatonin: A Multitasking Molecule.
  110. The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial.
  111. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial.
  112. Magnesium deficiency in critical illness.
  113. Daily magnesium fluxes regulate cellular timekeeping and energy balance.
  114. Efficacy of oral magnesium administration on decreased exercise tolerance in a state of chronic sleep deprivation.